https://www.selleckchem.com/pr....oducts/as2863619.htm
Clinical trial data from the U.S. Food and Drug Administration premarket approval studies supports multifocal and EDOF lenses as an effective treatment for aphakia and presbyopia. [J Refract Surg. 2021;37(2)98-104.]. Clinical trial data from the U.S. Food and Drug Administration premarket approval studies supports multifocal and EDOF lenses as an effective treatment for aphakia and presbyopia. [J Refract Surg. 2021;37(2)98-104.]. To evaluate the visual, refractive, topographic, and aberrometric outcomes after intracorneal ring segment
Like
Comment
Share
